Skin Therapy Letter-Family Practice Edition | |
Valacyclovir for the Management of Herpes Viral Infections | |
关键词: herpes virus; antiviral; herpes simplex; varicella-zoster; | |
DOI : | |
学科分类:医学(综合) | |
来源: Skin Therapy Letter-Family Practice Edition | |
【 摘 要 】
The Herpesviridae family (Types 1-8) continues to inflict considerable morbidity and social stigma upon humanity. Once infected with the herpes viruses, especially Types 1-3, they establish permanent residence within our nervous system and reactivate during periods of stress, trauma, and/or other precipitating factors. To date, there is no cure for herpes viral infections but antivirals can attenuate the symptoms and duration of episodic outbreaks. Prophylactic therapy can suppress recurrences. The first antiviral with selective activity against virus-infected cells is considered to be acyclovir. Our article will highlight the clinical indications of the current generation, valacyclovir, which is a prodrug of acyclovir. We consider valacyclovir as a second-generation antiviral, having taken into account the initial selectivity and safety profile of its progenitor, acyclovir.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912040572871ZK.pdf | 129KB | download |